We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Resmed Inc (RMD) Com Stk USD 0.004

Sell:$178.81 Buy:$178.93 Change: $0.34 (0.19%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:$178.81
Buy:$178.93
Change: $0.34 (0.19%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:$178.81
Buy:$178.93
Change: $0.34 (0.19%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.

Contact details

Address:
9001 Spectrum Center Blvd
SAN DIEGO
92123-1438
United States
Telephone:
+1 (858) 7462400
Website:
https://www.resmed.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
RMD
ISIN:
US7611521078
Market cap:
$25.57 billion
Shares in issue:
147.09 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Michael Farrell
    Chairman of the Board, Chief Executive Officer
  • Brett Sandercock
    Chief Financial Officer
  • Vered Keisar
    Chief People Officer
  • Lucile Blaise
    Senior Vice President - Strategy & Business Development
  • Urvashi Tyagi
    Chief Technology Officer
  • Todd Friedman
    Chief Information Security Officer
  • Katrin Pucknat
    Chief Marketing Officer
  • Michael Rider
    General Counsel, Company Secretary, Chief Legal Officer
  • Amy Wakeham
    Chief Investor Relations Officer
  • Jim Ellis
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.